Clinical trial · Interventional
Raman Spectroscopy for Liver Tumours Following Liver Surgery
Raman Spectral Imaging for Liver Tumours Following Liver Surgery
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of the proposed research is to develop a quick and reliable method for automated evaluation of tissue sections for residual tumour in histology specimens following liver surgery. This advanced technology will enable assessment of liver tumours and resection margins following liver surgery. The technology is based on Raman spectroscopy (RS) and multivariate spectral analysis to produce 2-dimensional biochemical images that can reliably separate the spectral signal of liver tumours from surrounding normal tissue.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colorectal Cancer Metastatic | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Raman Spectrometry | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Colorectal liver metatases
- description
- Liver tissue containing colorectal liver metastases
- interventionNames
- Device: Raman Spectrometry
Primary outcomes (1)
- measure
- Raman spectroscopy is able to discriminate between healthy liver tissue and colorectal liver metastases.
- timeFrame
- 3 years
- description
- To determine whether Raman spectroscopy can discriminate between healthy liver tissue and liver tumours.
Secondary outcomes (1)
- measure
- Tissue sections can be analysed by Raman spectroscopy more time effectively than normal clinical practice.
- timeFrame
- 3 years
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients undergoing surgery for liver tumours (colorectal liver metastases). * Able to give informed consent. Exclusion Criteria: • Patients where there is any doubt regarding the diagnosis from pathologist as ascertained by previous diagnostic biopsy.
References
Publications (0)
Data not yet available